Cell & Gene Therapy Platforms
Category VIEW ALL
Engineering of assembloid culture for an integrated 3D tissue formation
Technology No. 2025-PARK-71242
Novel Vaccine Formulations for Mycobacterium Tuberculosis and use of Thereof
Technology No. 2019-MITT-68665
NgAgo as a DNA-guided Gene Editing Tools in Prokaryotes and Eukaryotes
Technology No. 2018-SOLO-68167
Novel Adenoviral Vector System for Gene Delivery
Technology No. 2018-MITT-68142
Use of an MK2 Inhibitor to Enhance Nerve Regeneration
Technology No. 65383
Cell-Mediated Silica Sol-Gel Encapsulation of Living Cells and Tissues
Technology No. 65213
Peptide Silane Material
Technology No. 64710
Adenoviral Vector-based Vaccine for Influenza
Technology No. 64187
Engineered Natural Killer Cells Redirected Toward Purinergic Signaling
Technology No. 2019-MATO-68613
Live Cell Conjugation Chemistry for Imaging, Sensing and Cell Therapy
Technology No. 2018-CHOP-68209
Novel, Direct Contact Blood Brain Barrier Triculture
Technology No. 2015-KNIP-67191
Fabrication Method for Stratified and Layered Tissue to Repair Osteochondral Defects
Technology No. 65533
Surface Polydiacetylene Arrays as Substrates for Thiol-ene Click Reactions
Technology No. 2023-CLAR-69945
Deterministic Culturing of Single Cells in 3D
Technology No. 2020-SAVR-69076
Use of Ultrathin Striped Molecular Films on Soft Materials to Direct Cell Adhesion and Growth
Technology No. 2020-CLAR-68802
Ligand-mediated Targeting of Cytokine Interleukin-27 Enhances its Bioactivity
Technology No. 2020-FIGU-68875
Development of a novel cytokine-like Propeptide gene therapy platform
Technology No. 2023-FIGU-70017
Enhanced immunotherapy of "cold" solid tumors using Tumor tropic S. Typhimurium expressing anti-cancer proteins
Technology No. 2024-HE-70612
Nanopuff: Albumin-coated siRNA-bound polydopamine nanoparticles
Technology No. 2023-YEO-70458
A Novel Nanoparticle Adjuvant for Cancer Vaccines
Technology No. 2023-HOGE-70112
Biomimetic Glycosaminoglycan-based Scaffolds Improve Skeletal Muscle Regeneration in a Murine Volumetric Muscle Loss Model
Technology No. 2020-DENG-69068
Harnessing Nerve-Muscle Interaction for Accelerating Skeletal Muscle Repair
Technology No. 2020-DENG-69055
Next generation SARS-CoV-2 vaccines for emerging variants
Technology No. 2025-MITT-71007
Unique Adenoviral Vector-Based Universal Influenza Vaccine
Technology No. 2025-MITT-70855
Isothiourea Catalyzed Stereoselective Glycosylation
Technology No. 2023-AXEL-70326
Novel Strategy to Develop a Universal Influenza Vaccine
Technology No. 2022-MITT-69569
Layered 2D Functional Materials and Their Integration into a Nuclei Acid Pathogen Detection Device
Technology No. 2021-STAN-69260
Novel Approach to Induce Protection against Respiratory Viruses
Technology No. 2021-MITT-69166